Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Adenike R. Adelakun, BPharm, MSc

GSK, Canada

Disclosure(s): GSK: employee

Poster(s):

(P-576) Real-world Experience with the Two-Drug Regimen Dolutegravir/Lamivudine for the Treatment of HIV-1 among Vulnerable People Living with HIV in Canada: Preliminary Results from a Chart Review Study

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT